Indegene Limited
It is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way.
What Indegene files
- Others70
- Investor Meet67
- Updates40
- Important23
- JV/Acquisition10
- Board Meeting8
Indegene kicked off FY27 with robust Q1 performance, achieving revenue of ₹1,063.1 Cr (USD 112.5M), up 39.7% YoY in INR and 26.5% in USD. Profit After Tax (PAT) was ₹116.2 Cr, with EBITDA margins at 16.9%. The company expanded its active client base to 105, adding 35 new clients YoY,...
### Financial Highlights: Indegene reported strong financial performance for the recent quarter, with revenue from operations at INR 7,556 Mn, marking a 12.3% YoY increase. The consolidated annual revenue grew by 9.6% YoY, reaching INR 28,393 Mn. In terms of profitability, the PAT margin hit 15.6% for Q4, with a...
Financial Performance: Indegene Limited has demonstrated strong financial health with notable improvements across various metrics. Revenue growth is indicated, driven by increased demand for its generative AI solutions in life sciences. The company reported a significant increase in profit margins reflecting operational efficiency and cost control measures. Earnings per share...
Q3FY25 results showcase a solid performance for Indegene Limited, with revenue from operations reaching ₹7,204 million, reflecting a 4.9% QoQ and 7.0% YoY growth. The EBITDA margin improved to 20.8%, driven by operational efficiencies and stronger client engagements, while the PAT margin rose to 15.2% with profit after tax increasing...
Indegene Limited reported an 8.0% year-over-year revenue growth for Q2 FY25, reaching INR 6,868 million, with a profit after tax of INR 917 million, up 22.3% from the previous year. The company maintains strong client relationships, with 68 active clients contributing to its revenue primarily from biopharma. The PAT margin...